The company has outstanding warrants to management and the board of directors of 3,279,553 and to employees of Psyros Diagnostics Ltd. of 8,304,510 which can result in a total of 11,584,063 shares and can thus cause dilution.
Prolight Diagnostics’ share is traded on the Nordic Growth Market, NGM SME, under the name PRLD.